Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis

International Journal of Molecular Medicine

Volumn 22, Issue 4, 2008, Pages 459-464

  Svesson, Per Arne ^a,b   Olson, Fredrik J ^a,b   Hägg, Daniel A ^a,b   Ryndel, Mikael ^a,b   Wiklund, Olov ^b   Karlström, Lars ^a   Hulthe, Johannes ^c   Carlsson, Lena M S ^a,b   Fagerberg, Björn ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Atherosclerosis; Carotid stenosis; Immunohistochemistry; Plasminogen activator; Urokinase receptor

Indexed keywords

CD68 ANTIGEN; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM; TISSUE SECTION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CELLS, CULTURED; ENDARTERECTOMY, CAROTID; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE;

EID: 54049116284     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000043     Document Type: Article

References (24)

1. Gronholdt ML: Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 19: 2-13, 1999.
2. Golledge J, Greenhalgh RM and Davies AH: The symptomatic carotid plaque. Stroke 31: 774-781, 2000.
3. Redgrave JN, Lovett JK, Gallagher PJ and Rothwell PM: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 113: 2320-2328, 2006.
4. Boyle JJ: Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3: 63-68, 2005.
5. Svensson PA, Hagg DA, Jernas M, Englund MC, Hulten LM, Ohlsson BG, Hulthe J, Wiklund O, Carlsson B, Fagerberg B and Carlsson LM: Identification of genes predominantly expressed in human macrophages. Atherosclerosis 177: 287-290, 2004.
6. Binder BR, Mihaly J and Prager GW: uPAR-uPA-PAI-l interactions and signaling: a vascular biologist's view. J Thromb Haemost 97: 336-342, 2007.
7. Shah PK: Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 41: 15S-22S, 2003.
8. Chavakis T, Kanse SM, May AE and Preissner KT: Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochem Soc Trans 30: 168-173,2002.
9. Chavakis T, Willuweit AK, Lupu F, Preissner KT and Kanse SM: Release of soluble urokinase receptor from vascular cells. J Thromb Haemost 86: 686-693, 2001.
10. Stephens RW, Nielsen HJ, Christensen U, Thorlacius-Ussing O, Sorensen S, Dano K and Brunner N: Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 91: 869-874, 1999.
11. Hoyer-Hansen G and Lund IK: Urokinase receptor variants in tissue and body fluids. Adv Clin Chem 44: 65-102, 2007.
12. Noda-Heiny H, Daugherty A and Sobel BE: Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol 15: 37-43, 1995.
13. Steins MB, Padro T, Schwaenen C, Ruiz S, Mesters RM, Berdel WE and Kienast J: Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagul Fibrinolysis 15: 383-391, 2004.
14. Ohlsson BG, Englund MC, Karlsson AL, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G and Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1 beta in macrophages. J Clin Invest 98: 78-89, 1996.
15. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
16. Hagg D, Englund MC, Jernas M, Schmidt C, Wiklund O, Hulten LM, Ohlsson BG, Carlsson LM, Carlsson B and Svensson PA: Oxidized LDL induces a coordinated upregulation of the glutathione and thioredoxin systems in human macrophages. Atherosclerosis 185: 282-289,2006.
17. Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM, Stahlman M, Olofsson SO and Hulten LM: Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 26: 1871-1876, 2006.
18. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD and Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374,1995.
19. Salame MY, Samani NJ, Masood I and deBono DP: Expression of the plasminogen activator system in the human vascular wall. Atherosclerosis 152: 19-28,2000.
20. Fach EM, Garulacan LA, Gao J, Xiao Q, Storm SM, Dubaquie YP, Hefta SA and Opiteck GJ: In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics 3: 1200-1210, 2004.
21. Murdoch C, Muthana M and Lewis CE: Hypoxia regulates macrophage functions in inflammation. J Immunol 175: 6257-6263, 2005.
22. Busso N, Peclat V, So A and Sappino AP: Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 56: 550-557,1997.
23. Mace KA, Hansen SL, Myers C, Young DM and Boudreau N: HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 118: 2567-2577, 2005.
24. Pawlak K, Pawlak D and Mysliwiec M: Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients. Thromb Res 121: 543-548, 2008.